HSP90AA1 and cancer: Moreover, inhibition of Hsp90 chaperone machinery results in proteasomal degradation of various client oncoproteins that are implicated in multiple signaling pathways in cancers, offering merit of circumventing the common drug resistance of classical chemotherapies [8].